Cardiovascular Disease and Chronic Pulmonary Disease Increase the Risk of Short-Term Major Postoperative Complications after Robotic-Assisted Radical Prostatectomy

Author:

Siech Carolin12ORCID,Gruber Antonia1,Wenzel Mike1ORCID,Humke Clara1,Karakiewicz Pierre I.2,Kluth Luis A.1,Chun Felix K. H.1,Hoeh Benedikt1,Mandel Philipp1

Affiliation:

1. Goethe University Frankfurt, University Hospital, Department of Urology, 60629 Frankfurt am Main, Germany

2. Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC H2X3E4, Canada

Abstract

Background and objectives: Certain comorbidities may be associated with a higher risk of complications after robotic-assisted radical prostatectomy. Material and Methods: Relying on a tertiary care database, we identified robotic-assisted radical prostatectomy patients (January 2014–March 2023). Short-term major postoperative complications were defined according to Clavien Dindo as ≥IIIa within 30 days after robotic-assisted radical prostatectomy. Results: Of 1148 patients, the rates of postoperative Clavien Dindo IIIa, Clavien Dindo IIIb, Clavien Dindo IVa, and Clavien Dindo IVb complications were 3.3%, 1.4%, 0.3%, and 0.2%, respectively. Of those, 28 (47%) had lymphoceles, and 8 (13%) had bleeding-associated complications. Patients with cardiovascular disease (8 vs. 4%) or chronic pulmonary disease (13 vs. 5%) were more likely to have complications. In multivariable logistic regression models, cardiovascular disease (odds ratio: 1.78; p = 0.046) and chronic pulmonary disease (odds ratio: 3.29; p = 0.007) remained associated with an increased risk of postoperative complications. Conclusions: Complications after robotic-assisted radical prostatectomy are predominantly manageable without anesthesia. Concomitant cardiovascular disease and chronic pulmonary disease were both associated with a higher risk of postoperative complications.

Publisher

MDPI AG

Reference34 articles.

1. Zentrum für Krebsregisterdaten, and Gesellschaft der Epidemiologischen Krebsregister in Deutschland e.V (2021). Krebs in Deutschland für 2017/2018, Zentrum für Krebsregisterdaten.

2. Deutsche Krebsgesellschaft, Deutsche Krebshilfe, and Arbeitsgemeinschaft Wissenschaftlicher Medizinischer Fachgesellschaften (2021). S3-Leitlinie Prostatakarzinom (Langversion), AWMF.

3. EAU Guidelines Office (2023). EAU Guidelines on Prostate Cancer. Edn. Presented at the EAU Annual Congress Milan 2023, EAU Guidelines Office.

4. The effect of minimally invasive prostatectomy on practice patterns of American urologists;Oberlin;Urol. Oncol. Semin. Orig. Investig.,2016

5. Modern paradigms for prostate cancer detection and management;Williams;Med. J. Aust.,2022

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3